Best Available Treatment Study (@batstudy) 's Twitter Profile
Best Available Treatment Study

@batstudy

An international study to evaluate therapeutic options for #PIMS-TS / #MIS-C to help identify which patients to treat and which treatments work.

ID: 1348675923718139905

linkhttps://bestavailabletreatmentstudy.co.uk/ calendar_today11-01-2021 16:59:40

19 Tweet

165 Followers

142 Following

Aubrey Cunnington (@acunningid) 's Twitter Profile Photo

With #COVID19 cases rising again, we're expecting more cases of PIMS-TS/MIS-C. We need to find the best treatments for this new condition. Healthcare professionals in 42 countries are already helping to do this in the Best Available Treatment Study bestavailabletreatmentstudy.co.uk/bats-update-no…

With #COVID19 cases rising again, we're expecting more cases of PIMS-TS/MIS-C. We need to find the best treatments for this new condition. Healthcare professionals in 42 countries are already helping to do this in the Best Available Treatment Study bestavailabletreatmentstudy.co.uk/bats-update-no…
Rolando Ulloa-Gutierrez (@rolandoug) 's Twitter Profile Photo

#MIS_C SĆ­ndrome Inflamatorio MultisistĆ©mico en LatinoamĆ©rica: nuestro estudio #REKAMLATINA3 retrospectivo + prospectivo, vĆ­a Ped Infect Diseases. Enrolando y hasta fin de la pandemia. REKAMLATINA:Red Enfermedad Kawasaki AmĆ©rica Latina Gabriela Ivankovich-Escoto Adriana Tremoulet Adriana Yock #PIMSTS #pedsID #pedsICU journals.lww.com/pidj/Fulltext/…

Best Available Treatment Study (@batstudy) 's Twitter Profile Photo

Clinicians around the world have recruited 399 patients with PIMS-TS/MIS-C into the Best Available Treatment Study to help understand the best treatments for this rare but important new disease in children To find out more and enrol patients, check out bestavailabletreatmentstudy.co.uk

Clinicians around the world have recruited 399 patients with PIMS-TS/MIS-C into the Best Available Treatment Study to help understand the best treatments for this rare but important new disease in children

To find out more and enrol patients, check out bestavailabletreatmentstudy.co.uk
Best Available Treatment Study (@batstudy) 's Twitter Profile Photo

Patients have been recruited from 157 sites in the highlighted countries in this truly international effort to identify the best treatments for #PIMS_TS / #MIS_C. Find out more and start enrolling patients by visiting: bestavailabletreatmentstudy.co.uk

Patients have been recruited from 157 sites in the highlighted countries in this truly international effort to identify the best treatments for #PIMS_TS / #MIS_C.

Find out more and start enrolling patients by visiting: bestavailabletreatmentstudy.co.uk
Vanessa Sancho-Shimizu (@sanchoshimizu) 's Twitter Profile Photo

Come join Infection Rounds TODAY Wednesday 3rdĀ February 16h– 17h Ā Centre for Paediatrics & Child Health Imperial Department of Infectious Disease James Seddon The changing landscape of multidrug-resistant tuberculosis in children’ Ā  Jethro Herberg Molecular pathogen testing in febrile children: results from the PERFORM study

Best Available Treatment Study (@batstudy) 's Twitter Profile Photo

We are excited to present our first findings from the BATS study at #ESPID2021 looking at treatment effectiveness in #MIS_C. Can't wait to see you there! ESPIDSociety

We are excited to present our first findings from the BATS study at #ESPID2021 looking at treatment effectiveness in #MIS_C. Can't wait to see you there! <a href="/ESPIDsociety/">ESPIDSociety</a>
Eric Topol (@erictopol) 's Twitter Profile Photo

2 new NEJM observational reports for IVIG +/- steroid treatment of multisystem inflammatory syndrome of children (MIS-C) 1 says it works 1 says it doesn't + an insightful Roberta DeBiasi editorial for why this may have occurred nejm.org/doi/full/10.10…

2 new <a href="/NEJM/">NEJM</a> observational reports for  IVIG +/- steroid treatment of multisystem inflammatory syndrome of children (MIS-C)
1 says it works 
1 says it doesn't
+ an insightful <a href="/VirusDocDeBiasi/">Roberta DeBiasi</a> editorial for why this may have occurred
nejm.org/doi/full/10.10…